Researchers from two Columbia University campuses have teamed up to develop a football helmet that detects concussion in real time.
Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
A community wellness center led by two P&S faculty members will strengthen initiatives in stroke prevention and mental health support.
A new study finds that periodically reanalyzing epilepsy patients' DNA may aid in diagnosis and treatment.
New video that reveals how immune cells breach the blood-brain barrier is giving scientists new ideas about treating multiple sclerosis.